Vista Pharmaceuticals Limited (BOM: 524711)
India
· Delayed Price · Currency is INR 11.57
-0.11 (-0.94%)
At close: Dec 27, 2024
Vista Pharmaceuticals Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
| Net Income | -33.69 | -45.12 | -56.62 | -8.89 | -20.09 | -36.77 | Upgrade
|
| Depreciation & Amortization | 7.31 | 7.2 | 6.18 | 6.16 | 7.28 | 13.46 | Upgrade
|
| Loss (Gain) From Sale of Investments | 0.03 | 0.04 | -0.14 | - | -0.24 | 0.12 | Upgrade
|
| Other Operating Activities | -2.45 | 5.54 | 20.63 | -8.39 | -1.3 | 2.9 | Upgrade
|
| Change in Accounts Receivable | -7.74 | -30.31 | -7.87 | -4.02 | 81.11 | -9.43 | Upgrade
|
| Change in Inventory | -16.65 | 8.91 | 16.51 | 3.54 | - | 15.64 | Upgrade
|
| Change in Accounts Payable | -3.09 | -3.97 | 24.36 | 2.62 | -43.21 | -0.92 | Upgrade
|
| Change in Other Net Operating Assets | -15.03 | 8.58 | -20.16 | -0.95 | -91.01 | 23.02 | Upgrade
|
| Operating Cash Flow | -71.3 | -49.14 | -17.11 | -9.93 | -67.47 | 8.03 | Upgrade
|
| Operating Cash Flow Growth | - | - | - | - | - | -75.67% | Upgrade
|
| Capital Expenditures | -5.13 | -7.9 | -12.7 | -0.14 | -2.99 | -2.44 | Upgrade
|
| Sale (Purchase) of Intangibles | - | - | - | - | - | -14.81 | Upgrade
|
| Investing Cash Flow | -5.13 | -7.9 | -12.7 | -0.14 | -2.99 | -17.25 | Upgrade
|
| Short-Term Debt Issued | - | 7.97 | - | - | - | 47.51 | Upgrade
|
| Long-Term Debt Issued | - | - | - | 6.74 | 31.86 | - | Upgrade
|
| Total Debt Issued | 8 | 7.97 | - | 6.74 | 31.86 | 47.51 | Upgrade
|
| Short-Term Debt Repaid | - | - | -3.46 | - | - | - | Upgrade
|
| Long-Term Debt Repaid | - | -22.47 | -22.47 | - | - | -4.49 | Upgrade
|
| Total Debt Repaid | -26.62 | -22.47 | -25.92 | - | - | -4.49 | Upgrade
|
| Net Debt Issued (Repaid) | -18.62 | -14.5 | -25.92 | 6.74 | 31.86 | 43.02 | Upgrade
|
| Issuance of Common Stock | 173.6 | 96.08 | 7.63 | - | 90 | - | Upgrade
|
| Other Financing Activities | -54.6 | -25.64 | 49.43 | 2.65 | -52.26 | -40.22 | Upgrade
|
| Financing Cash Flow | 100.38 | 55.94 | 31.14 | 9.39 | 69.61 | 2.8 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | - | 0 | -0 | -0 | - | Upgrade
|
| Net Cash Flow | 23.96 | -1.1 | 1.32 | -0.68 | -0.85 | -6.43 | Upgrade
|
| Free Cash Flow | -76.43 | -57.04 | -29.82 | -10.07 | -70.46 | 5.58 | Upgrade
|
| Free Cash Flow Margin | -83.74% | -55.44% | -297.07% | -255.34% | -556.35% | 2.45% | Upgrade
|
| Free Cash Flow Per Share | -1.45 | -1.31 | -0.81 | -0.27 | -2.03 | 0.18 | Upgrade
|
| Cash Interest Paid | 11.1 | 12.2 | 12.14 | 9 | 15.49 | 15.4 | Upgrade
|
| Cash Income Tax Paid | - | - | -10.53 | - | - | - | Upgrade
|
| Levered Free Cash Flow | -48.44 | -28.79 | -25.52 | -92.08 | 50.57 | -32.29 | Upgrade
|
| Unlevered Free Cash Flow | -41.42 | -21.08 | -17.34 | -86.47 | 60.22 | -23.76 | Upgrade
|
| Change in Net Working Capital | 20.65 | -4.03 | -17.33 | 81.07 | -71.29 | -18.43 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.